Evergreen corporate venture fund of Boehringer Ingelheim, one of the world's largest pharma companies. Invests in early-stage biotech startups in oncology, regenerative medicine, infectious diseases, and digital health. 70+ investments since 2010.
Learn what Boehringer Ingelheim Venture Fund and similar investors look for:
Biotech pitch guideHealthtech pitch guideTips, programs, and cultural notes